CLOSTRIDIUM DIFFICILE INFECTION (CDI)

A Phase 3, randomized, double-blind, active controlled study to compare the efficacy and safety of ridinilazole with vancomycin in the treatment of Clostridium difficile infection (CDI).

You may qualify if:

• Have been diagnosed with infection for Clostridium difficile within the past 24 hours and have not started antibiotic treatment.